Custom Converting, Inc.January 16, 2026

FDA 483 - Custom Converting, Inc. - January 16, 2026

Record Details

Custom Converting, Inc. in Oceanside, CA, a patch manufacturer, received two observations during an FDA inspection. The firm was cited for not having written procedures for its quality control unit, specifically regarding the annual review of reserve samples. Additionally, the firm failed to conduct annual product reviews for products manufactured in 2024.

Company: Custom Converting, Inc.
Inspection Date: January 16, 2026
Product Type: Drugs
Office: Los Angeles District Office
Person: Darren S. Brown (Consumer Safety Officer)

Open in Dashboard

ID · 83d5b0a2-9419-491f-9021-f4d391457186